Stock Events

Stock Events

Halozyme Therapeutics (HALO) Q2 2016 Earnings

9MayConfirmed

Q3 2015

Q4 2015

Q1 2016

Q2 2016

-0.2

-0.12

-0.05

0.03

Details

Expected EPS

-0.2

Actual EPS

-0.16

Surprise EPS

0.04

Surprise Percent

+20%

Description

Halozyme Therapeutics (HALO) has reported earnings of -0.16 per share for Q2 2016.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.